Early Alzheimer’s Study – Now Enrolling
Early Alzheimer’s Disease: Engage
Having memory problems? Trouble thinking clearly?
If this sounds like you, or someone you know, please consider the ENGAGE Study. The ENGAGE Study is a global study assessing the efficacy and safety of an investigational medication, to determine whether it can slow the progression of symptoms in early Alzheimer’s disease. There is an important medical and scientific need to research therapies that could delay memory loss and the progression of disability in Alzheimer’s disease because there are currently no approved treatments that slow the course of the condition.
You may be able to take part in the ENGAGE Study if you:
- are 50–85 years of age
- are experiencing symptoms that might be related to early Alzheimer’s disease, such as problems with memory or thinking clearly
You will need a study partner – someone who is close to you, such as a family member or close friend – to attend certain study visits with you and provide information on your health and well-being. If eligible, all study medication, examinations, and medical care related to the study will be provided at no cost to you. Reasonable compensation for time and travel may be provided. If you, or someone you know, would like more information about taking part in the ENGAGE Study, and to help us to further research and advance a potential treatment option for early Alzheimer’s disease, please contact the study team using the details below.
If you, your family member or loved one is interested in learning more about participating in this study, please contact the ENGAGE Study Coordinator at 520-320-2157.